Shin Poong Pharm.Co.,Ltd.
KRX:019170.KS
12730 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 200,228.583 | 209,287.628 | 189,237.235 | 197,750.767 | 189,721.696 | 187,389.168 | 184,998.4 | 194,147.338 | 195,950.486 | 220,291.938 | 215,962.84 | 221,169.38 | 229,693.072 | 232,060.469 | 217,255.761 | 188,135.653 | 165,922.224 |
| Cost of Revenue
| 121,608.743 | 131,314.541 | 111,849.721 | 121,223.562 | 113,536.906 | 111,504.09 | 104,877.354 | 106,220.013 | 109,265.364 | 119,328.328 | 120,449.943 | 131,781.322 | 126,557.925 | 121,330.706 | 112,105.524 | 92,307.69 | 86,023.353 |
| Gross Profit
| 78,619.839 | 77,973.087 | 77,387.514 | 76,527.205 | 76,184.79 | 75,885.078 | 80,121.047 | 87,927.325 | 86,685.122 | 100,963.61 | 95,512.897 | 89,388.058 | 103,135.148 | 110,729.763 | 105,150.237 | 95,827.963 | 79,898.871 |
| Gross Profit Ratio
| 0.393 | 0.373 | 0.409 | 0.387 | 0.402 | 0.405 | 0.433 | 0.453 | 0.442 | 0.458 | 0.442 | 0.404 | 0.449 | 0.477 | 0.484 | 0.509 | 0.482 |
| Reseach & Development Expenses
| 56,019.404 | 30,382.745 | 17,334.438 | 5,622.301 | 5,966.503 | 4,869.822 | 4,625.718 | 6,386.456 | 9,136.637 | 5,751.315 | 3,585.036 | 6,272.638 | 4,823.106 | 5,093.911 | 45.019 | 656.595 | 867.64 |
| General & Administrative Expenses
| 7,589.366 | 111,991.773 | 5,955.033 | 5,492.756 | 5,295.904 | 5,185.406 | 5,314.121 | 6,238.769 | 6,432.42 | 4,570.188 | 5,833.848 | 6,791.781 | 6,663.461 | 11,580.477 | 11,044.429 | 14,482.666 | 12,059.171 |
| Selling & Marketing Expenses
| 29,276.524 | 28,362.985 | 23,996.087 | 21,912.382 | 20,795.31 | 18,946.024 | 21,620.621 | 22,313.413 | 20,359.669 | 20,354.158 | 18,063.269 | 16,765.066 | 17,023.476 | 14,973.998 | 24,020.797 | 21,617.898 | 18,589.503 |
| SG&A
| 71,576.084 | 111,991.773 | 29,951.12 | 27,405.138 | 26,091.214 | 24,131.43 | 26,934.742 | 28,552.182 | 26,792.089 | 24,924.346 | 23,897.117 | 23,556.847 | 23,686.937 | 26,554.475 | 35,065.226 | 36,100.564 | 30,648.674 |
| Other Expenses
| 491.989 | -30,382.745 | 44,408.36 | 35,654.25 | 38,524.927 | 39,131.206 | 186.71 | -10,494.791 | 204.305 | -29.764 | 459.089 | -293.761 | 127.032 | -886.11 | -569.623 | -583.763 | -116.064 |
| Operating Expenses
| 127,595.488 | 111,991.773 | 91,693.918 | 68,681.689 | 70,582.644 | 68,132.458 | 72,306.321 | 78,358.857 | 82,449.513 | 81,711.859 | 70,701.511 | 65,153.708 | 64,834.662 | 66,755.706 | 69,883.492 | 64,591.732 | 60,720.973 |
| Operating Income
| -48,975.649 | -34,018.686 | -9,044.916 | 11,348.273 | 8,424.498 | 10,685.502 | 7,814.725 | 9,568.468 | 4,235.609 | 19,251.751 | 24,811.386 | 24,234.35 | 38,295.422 | 43,974.057 | 35,266.744 | 31,236.233 | 19,177.9 |
| Operating Income Ratio
| -0.245 | -0.163 | -0.048 | 0.057 | 0.044 | 0.057 | 0.042 | 0.049 | 0.022 | 0.087 | 0.115 | 0.11 | 0.167 | 0.189 | 0.162 | 0.166 | 0.116 |
| Total Other Income Expenses Net
| 2,048.335 | -762.851 | 59.271 | -3,008.483 | -1,305.886 | -5,503.183 | -6,113.803 | -13,271.635 | -2,070.133 | -5,745.035 | -5,136.596 | -6,180.669 | -6,807.583 | -5,630.59 | -4,460.05 | -10,803.369 | -3,718.959 |
| Income Before Tax
| -46,927.314 | -34,781.537 | -8,985.645 | 8,339.79 | 7,118.612 | 5,182.319 | 1,700.923 | -3,703.167 | 2,165.477 | 13,506.716 | 19,674.791 | 18,053.681 | 31,492.903 | 38,343.467 | 30,806.695 | 20,432.862 | 15,458.939 |
| Income Before Tax Ratio
| -0.234 | -0.166 | -0.047 | 0.042 | 0.038 | 0.028 | 0.009 | -0.019 | 0.011 | 0.061 | 0.091 | 0.082 | 0.137 | 0.165 | 0.142 | 0.109 | 0.093 |
| Income Tax Expense
| 3,830.735 | 527.292 | 2,540.366 | 3,294.053 | 1,723.625 | 2,368.664 | 780.744 | 14,895.066 | 688.799 | 10,152.522 | 14,189.339 | 3,715.15 | 6,629.698 | 16,587.441 | 9,717.2 | 8,343.661 | 6,624.937 |
| Net Income
| -57,325.387 | -35,308.829 | -11,526.011 | 5,002.805 | 5,323.827 | 2,803.78 | 904.889 | -18,591.699 | 1,476.216 | 3,349.617 | 5,437.651 | 14,377.49 | 24,866.24 | 21,734.263 | 21,052.454 | 12,051.001 | 8,843.13 |
| Net Income Ratio
| -0.286 | -0.169 | -0.061 | 0.025 | 0.028 | 0.015 | 0.005 | -0.096 | 0.008 | 0.015 | 0.025 | 0.065 | 0.108 | 0.094 | 0.097 | 0.064 | 0.053 |
| EPS
| -1,118.28 | -688.79 | -224.84 | 99.4 | 106.53 | 56 | 25 | -392.02 | 35 | 99 | 133.65 | 353.18 | 611.62 | 530.57 | 498.93 | 285.23 | 209.13 |
| EPS Diluted
| -1,118.28 | -688.79 | -224.84 | 99.4 | 106.53 | 56 | 25 | -392.02 | 35 | 99 | 133.65 | 353.18 | 611.62 | 530.57 | 498.93 | 285.23 | 209.13 |
| EBITDA
| -37,067.259 | 77,973.087 | 3,630.373 | 23,556.761 | 20,738.915 | 22,051.097 | 18,220.115 | 9,114.541 | 18,661.596 | 33,876.693 | 38,790.979 | 33,731.28 | 47,604.179 | 52,285.211 | 43,874.549 | 34,808.543 | 25,795.17 |
| EBITDA Ratio
| -0.185 | 0.373 | 0.019 | 0.119 | 0.109 | 0.118 | 0.098 | 0.047 | 0.095 | 0.154 | 0.18 | 0.153 | 0.207 | 0.225 | 0.202 | 0.185 | 0.155 |